Borane;pyridine → N-(1-(4-chloro-3-ethoxybenzyl)piperidin-4-yl)-5-methylnicotinamide
반응식
CC1C=NC=C(C=1)C(NC1CCNCC1)=O.ClC1C=CC(C=O)=CC=1OCC.[Cl:29][C:30]1[CH:54]=[CH:53][C:33]([CH2:34][N:35]2[CH2:40][CH2:39][CH:38]([NH:41][C:42]([C:44]3[CH:45]=CC=[C:48]4[C:52]=3[NH:51][CH:50]=[CH:49]4)=[O:43])[CH2:37][CH2:36]2)=[CH:32][C:31]=1[O:55][CH2:56][CH3:57].B.N1C=CC=CC=1>ClCCCl.C(O)(=O)C>[Cl:29][C:30]1[CH:54]=[CH:53][C:33]([CH2:34][N:35]2[CH2:40][CH2:39][CH:38]([NH:41][C:42](=[O:43])[C:44]3[CH:45]=[C:49]([CH3:48])[CH:50]=[N:51][CH:52]=3)[CH2:37][CH2:36]2)=[CH:32][C:31]=1[O:55][CH2:56][CH3:57]참가 물질
7
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
To a solution of 5-methyl-N-(piperidin-4-yl)-nicotinamide (22 mg, 0.10 mmol), 4-chloro-3-ethoxy-benzaldehyde (22 mg, 0.12 mmol) in DCE:EtOH (1:11 mL) was added acetic acid (25 μL) and pyridine-borane complex (25 μL, 8M in pyridine, 0.2 mmol). The reaction was shaken for 16 h, after which time it was concentrated and purified by reversed phase HPLC (MeCN:H2O) affording the title compound (22 mg, 57%). MS: 388.4 (MH+)
후처리
- concentrationafter which time it was concentrated
- custompurified by reversed phase HPLC (MeCN:H2O)
출처 및 근거
- ORD 기록
- ord-9c544fc82ba740ae82223ec8cd956604
- 출처 데이터셋
- uspto-grants-2010_08
- 특허 번호
- US07772253B2
반응 노트
불러오는 중…